Clinical Trials Directory

Trials / Completed

CompletedNCT07343492

fMRI Reveal Functional Preservation in Glioma Peritumoral Edema

Individualized fMRI and Molecular Profiling Reveal Functional Preservation in Glioma Peritumoral Edema

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

he goal of this observational study is to investigate the functional and biological characteristics of the brain tissue surrounding diffuse gliomas, known as peritumoral edema (PTE). The study aims to determine if a non-invasive brain imaging technique, resting-state functional MRI (rs-fMRI), can identify which parts of this edematous tissue are functionally preserved. The main questions it aims to answer are: Can individualized rs-fMRI mapping accurately distinguish functionally active subregions from non-functional subregions within the peritumoral edema? Do these functionally preserved regions, identified by imaging, correspond to areas with lower tumor cell infiltration and higher neuronal integrity when examined microscopically? Participants prospectively enrolled for glioma resection surgery as part of their standard clinical care will undergo preoperative rs-fMRI. This imaging data will be used to create individualized functional network maps of the PTE. During the planned surgery, biopsies will be taken from PTE areas identified by the rs-fMRI analysis as "functionally preserved" and "non-preserved." These tissue samples will then undergo molecular analysis to assess markers for tumor proliferation (Ki-67), invasiveness (Nestin), neuronal integrity (NeuN), and synaptic density (PSD-95, Synapsin-1). Finally, the functional characteristics derived from the preoperative imaging will be correlated with the molecular profiles of the corresponding tissue samples.

Conditions

Timeline

Start date
2020-05-01
Primary completion
2025-01-01
Completion
2025-02-01
First posted
2026-01-15
Last updated
2026-01-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07343492. Inclusion in this directory is not an endorsement.